Gilead and PAHO agree to expedite lenacapavir access for HIV prevention
Gilead Sciences and the Pan American Health Organization (PAHO) have signed an agreement to expedite access to the company’s twice-yearly…
News
Eli Lilly and QurCan sign genetic medicine deal
Electra targets $342m IPO to fund hyperinflammatory syndrome drug’s pivotal trials
Agentic AI trust gap slowing healthcare provider adoption, survey reveals
GSK bolsters oncology pipeline with $750m Chimagen TCE deal
Definium tees up regulatory submission for psychedelic on Phase III hat trick
Cheplapharm to take over 20 medicines and three sites from Sanofi
FDA reduces monitoring time for Amgen’s Imdelltra infusions
